Celebrating our 10th anniversary – Unlock our special offer today

US FDA holds off on shutting down Juul sales to review ‘unique scientific issues’

The US Food and Drug Administration (FDA) has temporarily suspended the marketing denial order (MDO) it served on Juul Labs last month demanding the company remove its e-cigarettes from the US market. The administrative stay does not permanently rescind the order.

The federal agency claimed that “there are scientific issues unique to the Juul application warranting additional review”. It added: “All electronic nicotine delivery systems, or ENDS products, including those made by Juul, are required by law to have FDA authorisation to be legally marketed. The stay and the agency’s review does not constitute authorisation to market, sell, or ship Juul products.”

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization